BioWorld

Sep. 27, 2007

View Archived Issues

Some Blunt Talk About Money Highlights Kickoff of EuroBIO

Read More

Keryx, Japan Tobacco Deal: Possible $100M For Zerenex

Read More

Partnering Tables Turn As Big Pharma Pitches Biotech

Read More

Alemtuzumab In Phase III Testing Against Rebif In MS

Read More

GlobeImmune Is Advancing Tarmogen With $41M Series C

Read More

Amgen Cutbacks Hit Home As ECCO Data Tumble Forth

Read More

CollaGenex Drops Rosacea Drug After Phase II Failure

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Emergent Snags $448M Deal for Anthrax Vaccine

Emergent BioSolutions Inc. said Wednesday that it signed a three-year contract with the federal government worth up to $448 million to supply anthrax vaccine for the nation's biodefense stockpile. (BioWorld Today) Read More

NPS, Nycomed Enter Potential $185M Deal Covering Gattex

Read More